1. Asthma: Chronic Airway Inflammation
Asthma affects >300 million people worldwide. Key aspects:
- Bronchial hyperresponsiveness: exaggerated reaction to cold, allergens, exercise
- Eosinophilic inflammation: IL-4, IL-5, IL-13 → eosinophilic infiltration → epithelial damage
- TRPA1 / TRPV1: ion channels in sensory nerve fibers → reflexive bronchoconstriction
- Airway remodeling: TGF-β → subepithelial fibrosis → irreversible obstruction
- MUC5AC: hypermucus secretion → small airway obstruction
2. Ginger Mechanisms in Asthma
2.1 TRPA1/TRPV1 Desensitization
6-Gingerol and 8-gingerol transiently activate TRPA1 and then cause desensitization → reduced neurogenic bronchoconstriction via C fibers. TRPV1 modulation reduces substance P release → reduced neurogenic inflammation.
2.2 Anti-Eosinophilic Inflammation (NF-κB/IL-5)
Gingerols inhibit NF-κB in Th2 lymphocytes and dendritic cells: IL-4 −38%, IL-5 −44%, IL-13 −31%. Bronchoalveolar lavage shows eosinophils −52% in asthma models.
2.3 Mast Cell Degranulation Inhibition
6-Gingerol inhibits histamine and LTC4 release by sensitized mast cells → reduced immediate allergic reaction.
2.4 MUC5AC Reduction (Mucus)
Via inhibition of EGFR/STAT6 in goblet cells: MUC5AC expression decreases → less hyperviscous mucus → improved mucociliary clearance.
2.5 Anti-Remodeling
TGF-β/Smad inhibition → reduced subepithelial fibrosis and smooth muscle hypertrophy in chronic asthma models (8 weeks of treatment).
3. Comparison: Sugar-Free Ginger Shot vs. Other Supplements for Asthma
| Supplement | Mechanism | TRPA1 | Anti-eosinophilic | Anti-remodeling |
|---|---|---|---|---|
| Ginger (INTI) | TRPA1, NF-κB, MUC5AC | ✅ Desens. | ✅ IL-5 −44% | ✅ TGF-β |
| Curcumin | NF-κB, IL-4/IL-5 | ❌ Little | ✅ Moderate | ✅ Partial |
| Quercetin | Mast cells, IL-13 | ❌ Not doc. | ✅ Moderate | ❌ Little |
| Boswellia | LOX-5 (leukotrienes) | ❌ No | ✅ LTC4 | ❌ Little |
| Magnesium | Direct bronchodilation | ❌ No | ❌ No | ❌ No |
4. Usage Protocol for Asthma
| Parameter | Recommendation |
|---|---|
| Form | Artisanal preparation (gingerols intact) |
| Daily dose | 1–2 INTI shots (200–400 mg gingerols) |
| Timing | Morning + before ginger and sport/allergen exposure |
| Minimum duration | 8 weeks (anti-remodeling effect) |
| Combination | Quercetin, vitamin D (Th1/Th2 balance) |
| Note | Does NOT replace prescribed bronchodilators |
❓ FAQ — Ginger & Asthma
Can ginger replace my Ventolin?
No. Bronchodilators for attacks remain essential. Ginger acts as preventive inflammatory modulation, not acute attack treatment.
TRPA1: agonist or antagonist?
6-Gingerol is a partial TRPA1 agonist that causes rapid desensitization. A slight warm sensation in the throat is normal and transient.
Allergic asthma vs. exercise-induced asthma?
The mechanisms (NF-κB eosinophil for allergy, TRPA1 neural for exercise/cold) suggest benefit for both types, but human clinical data are limited.
Artisanal preparation vs. ginger powder?
Cold pressing preserves the TRPA1-active gingerols. Heating partially converts them into shogaols with a different profile.
Made in Belgium for healthy airways and a balanced immune system.
→ Discover INTI at inti-drink.com
Related Articles
Read more about related topics:
- Ginger & Interstitial Cystitis: NF-κB, TRPV1, and Bladder Inflammation (2025)
- Ginger & Dizziness: TRPV1, 5-HT3, and Vestibular System (2025)
- Ginger & Raynaud's Syndrome: Microcirculation, TRPV1 and Vasodilation (2025)
- fibromyalgia-centrale-sensitisatie-substance-p-diffuse-pijn-wetenschap">Ginger and fibromyalgia: central sensitization, substance P and diffuse pain — what does science say?
- Ginger and airways: asthma, COPD, bronchitis and mucus production (NF-κB, mucin, phosphodiesterase, TRPV1)
- Neuropathic Pain Belgium: TRPV1, Substance P and Ginger Antinociceptive
- Ginger and tendonitis, bursitis and plantar fasciitis: COX-2, VEGF tendon and NF-κB — sports protocol — INTI
- Ginger and acute lower back pain: sciatica, lumbago and hernia — urgent anti-inflammatory protocol — INTI
- Choosing a selection results in a full page refresh.
- Opens in a new window.